Pharmacovigilance and clinical environment: utilizing OMOP-CDM and OHDSI software stack to integrate EHR data

VK Dimitriadis, GI Gavriilidis… - Public Health and …, 2021 - ebooks.iospress.nl
Abstract Information Technology (IT) and specialized systems could have a prominent role
towards the support of drug safety processes, both in the clinical context but also beyond …

An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources

H Shin, S Lee - BMC Medical Informatics and Decision Making, 2021 - Springer
Abstract Background Adverse drug reactions (ADRs) are regarded as a major cause of
death and a major contributor to public health costs. For the active surveillance of drug …

Supporting active pharmacovigilance via IT tools in the clinical setting and beyond: Regulatory and management aspects

P Natsiavas, GI Gavriilidis, Z Linardaki… - The Importance of …, 2020 - ebooks.iospress.nl
Abstract Information Technology (IT) could have a prominent role towards the “Active
Pharmacovigilance”(AP) paradigm by facilitating the analysis of potential Adverse Drug …

[HTML][HTML] ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model

Y Yu, KJ Ruddy, N Hong, S Tsuji, A Wen… - Journal of biomedical …, 2019 - Elsevier
Abstract Objective Supplementing the Spontaneous Reporting System (SRS) with Electronic
Health Record (EHR) data for adverse drug reaction detection could augment sample size …

An open-source platform integrating emerging data sources to support multi-modal active pharmacovigilance

VK Dimitriadis, S Dimitsaki, A Chytas… - Frontiers in Drug …, 2023 - frontiersin.org
As new data sources have emerged, the data space which Pharmacovigilance (PV)
processes can use has significantly expanded. However, still, the currently available tools …

From data silos to standardized, linked, and FAIR data for pharmacovigilance: current advances and challenges with observational healthcare data

V Koutkias - Drug Safety, 2019 - Springer
Pharmacovigilance (PV) encompasses all data gathering and processing activities related to
the detection, assessment, understanding, and prevention of adverse effects throughout the …

Back to the future: the evolution of pharmacovigilance in the age of digital healthcare

MA Ibara, RL Richesson - Clinical research informatics, 2023 - Springer
Pharmacovigilance is the science and activities relating to the detection, assessment,
understanding, and prevention of adverse effects from medicines or vaccines …

[HTML][HTML] Integrating electronic health record data into the ADEpedia-on-OHDSI platform for improved signal detection: a case study of immune-related adverse events

Y Yu, KJ Ruddy, A Wen, N Zong, S Tsuji… - AMIA Summits on …, 2020 - ncbi.nlm.nih.gov
With widespread adoption of electronic health records (EHRs), Real World Data and Real
World Evidence (RWE) have been increasingly used by FDA for evaluating drug safety and …

Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies

VG Koutkias, A Lillo-Le Louët… - Expert opinion on drug …, 2017 - Taylor & Francis
Objective: Driven by the need of pharmacovigilance centres and companies to routinely
collect and review all available data about adverse drug reactions (ADRs) and adverse …

The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools

JL Oliveira, P Lopes, T Nunes… - … and drug safety, 2013 - Wiley Online Library
Purpose Pharmacovigilance methods have advanced greatly during the last decades,
making post‐market drug assessment an essential drug evaluation component. These …